Importance of the structure of the RGD-containing loop in the disintegrins echistatin and eristostatin for recognition of alpha IIb beta 3 and alpha v beta 3 integrins

被引:75
作者
McLane, MA
VijayKumar, S
Marcinkiewicz, C
Calvete, JJ
Niewiarowski, S
机构
[1] TEMPLE UNIV,SCH MED,DEPT BIOCHEM,PHILADELPHIA,PA 19140
[2] TEMPLE UNIV,SCH MED,FELS RES INST,PHILADELPHIA,PA 19140
[3] TEMPLE UNIV,SCH MED,DEPT PHYSIOL,PHILADELPHIA,PA 19140
[4] TIERARZTL HSCH,HANNOVER KIRCHRODE,GERMANY
关键词
RGD loop; integrin alpha IIb beta 3; integrin alpha v beta 3; disintegrin; disulfide bridge;
D O I
10.1016/0014-5793(96)00716-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Echistatin and eristostatin are structurally homologous disintegrins which exhibit significant functional differences in interaction with various integrins, We hypothesized that this may reflect differences in the sequences of their RGD loops: (20)CKRARGDDMDDYC(32) and (23)CRVARGDWNDDYC(35), respectively, Mapping of eristostatin peptides obtained by proteolytic digestion suggested that it has the same alignment of S-S bridges as echistatin, Synthetic echistatin D27W resembled eristostatin since it had increased platelet aggregation inhibitory activity, increased potency to block fibrinogen binding to alpha IIb beta 3, and decreased potency to block vitronectin binding to alpha v beta 3 as compared to wild-type echistatin, Since eristostatin and echistatin have a similar pattern of disulfide bridges, we constructed molecular models of eristostatin based on echistatin NMR coordinates, The RGD loops of eristostatin and echistatin D27W were wider than echistatin's due to the placement of tryptophan (rather than aspartic acid) immediately after the RGD sequence, We propose a hypothesis that the width and shape of the RGD loop are important ligand structural features that affect fitting of ligand to the binding pocket of alpha IIb beta 3 and alpha v beta 3.
引用
收藏
页码:139 / 143
页数:5
相关论文
共 28 条
  • [1] SOLUTION STRUCTURE OF KISTRIN, A POTENT PLATELET-AGGREGATION INHIBITOR AND GP-IIB-IIIA ANTAGONIST
    ADLER, M
    LAZARUS, RA
    DENNIS, MS
    WAGNER, G
    [J]. SCIENCE, 1991, 253 (5018) : 445 - 448
  • [2] ASSIGNMENT OF ALL 4 DISULFIDE BRIDGES IN ECHISTATIN
    BAUER, M
    SUN, YP
    DEGENHARDT, C
    KOZIKOWSKI, B
    [J]. JOURNAL OF PROTEIN CHEMISTRY, 1993, 12 (06): : 759 - 764
  • [3] SLOW-COOLING PROTOCOLS FOR CRYSTALLOGRAPHIC REFINEMENT BY SIMULATED ANNEALING
    BRUNGER, AT
    KRUKOWSKI, A
    ERICKSON, JW
    [J]. ACTA CRYSTALLOGRAPHICA SECTION A, 1990, 46 : 585 - 593
  • [4] THE DISULFIDE BRIDGE PATTERN OF SNAKE-VENOM DISINTEGRINS, FLAVORIDIN AND ECHISTATIN
    CALVETE, JJ
    WANG, YQ
    MANN, K
    SCHAFER, W
    NIEWIAROWSKI, S
    STEWART, GJ
    [J]. FEBS LETTERS, 1992, 309 (03) : 316 - 320
  • [5] CALVETE JJ, 1991, IBOCHEMISTRY, V30, P225
  • [6] BINDING OF GLYCOPROTEIN-IIIA-DERIVED PEPTIDE-217-231 TO FIBRINOGEN AND VONWILLEBRAND-FACTORS AND ITS INHIBITION BY PLATELET GLYCOPROTEIN-IIB/IIIA COMPLEX
    COOK, JJ
    TRYBULEC, M
    LASZ, EC
    KHAN, S
    NIEWIAROWSKI, S
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1119 (03) : 312 - 321
  • [7] H-1-NMR STUDIES OF ECHISTATIN IN SOLUTION - SEQUENTIAL RESONANCE ASSIGNMENTS AND SECONDARY STRUCTURE
    DALVIT, C
    WIDMER, H
    BOVERMANN, G
    BRECKENRIDGE, R
    METTERNICH, R
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1991, 202 (02): : 315 - 321
  • [8] BINDING INTERACTIONS OF KISTRIN WITH PLATELET GLYCOPROTEIN-IIB-IIIA - ANALYSIS BY SITE-DIRECTED MUTAGENESIS
    DENNIS, MS
    CARTER, P
    LAZARUS, RA
    [J]. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 1993, 15 (03) : 312 - 321
  • [9] GAN ZR, 1988, J BIOL CHEM, V263, P19827
  • [10] CHEMICAL SYNTHESIS OF ECHISTATIN, A POTENT INHIBITOR OF PLATELET-AGGREGATION FROM ECHIS-CARINATUS - SYNTHESIS AND BIOLOGICAL-ACTIVITY OF SELECTED ANALOGS
    GARSKY, VM
    LUMMA, PK
    FREIDINGER, RM
    PITZENBERGER, SM
    RANDALL, WC
    VEBER, DF
    GOULD, RJ
    FRIEDMAN, PA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (11) : 4022 - 4026